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through homologous recombination show deficits in These results leave several questions open. Does the
spatial learning and a decrease in the protein synthesis± LTD-inducing protocol stimulate CREB phosphorylation
dependent late phase of hippocampal LTP (but show on Ser-133 and does it activate CREB-mediated gene
normal early-phase LTP). In hippocampal neurons, CREB transcription? Is such phosphorylation directly medi-
phosphorylation depends on complicated and inter- ated by CaMKIV or does this kinase act through other
acting kinase cascades, involving an ERK/MAP kinase signaling pathways? Is CREB activation required for late
cascade, PKA (Impey et al., 1998), and CaMKIV (Diesser- LTD that is induced by synaptic stimulation in cerebellar
oth et al., 1998). slices? Do mice deficient in CREB exhibit deficits in
So far, examples of CREB-mediated synaptic plastic- cerebellar-dependent motor learning? Finally, is CREB
ity all involve the long-term enhancement of synaptic also required for hippocampal late LTD? And if so, how
transmission (i.e., LTP and long-term facilitation). How- can activation of a single transcription factor contribute
ever, synapses also display long-term decreases in syn- to both synaptic potentiation and depression? Clearly,
aptic transmission, such as long-term depression (LTD) CREB's new role as a regulator of synaptic depression
(see Linden and Connor, 1995). Up until now, it had not provides a powerful potentiating stimulus for future
been known whether CREB-regulated gene expression studies.
is also necessary for these inhibitory forms of synaptic
plasticity. And if gene activation by CREB is required Steven A. Siegelbaum
for long-term decreases in synaptic strength, what are Center for Neurobiology and Behavior
the upstream signaling cascades that are needed for its Department of Pharmacology
recruitment? In this issue of Neuron, Ahn, Ginty, and Howard Hughes Medical Institute
Linden (1999) address these questions for the late, pro-
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tein synthesis±dependent phase of LTD in cultured cere-
New York, New York 10032
bellar Purkinje neurons.
Cerebellar LTD was initially described as a prolonged
Selected Readingsdecrease in synaptic transmission between parallel fi-
bers of presynaptic granule cells and postsynaptic Pur- Ahn, S., Ginty, D.D., and Linden, D.J. (1999). Neuron 23, this issue,
kinje neurons (Linden and Connor, 1995). It is typically 559±568.
induced by pairing climbing fiber stimulation, which pro- Deisseroth, K., Heist, E.K., and Tsien, R.W. (1998). Nature 392,
duces a large excitatory response in the Purkinje neuron, 198±202.
with granule cell stimulation. Although the mechanism Impey, S., Obrietan, K., Wong, S.T., Poser, S., Yano, S., Wayman,
of LTD induction in cerebellar brain slices is somewhat G., Deloulme, J.C., Chan, G., and Storm, D.R. (1998). Neuron 21,
869±883.controversial, the Linden group has developed a simpli-
fied system to study LTD in isolated, cultured Purkinje Linden, D.J. (1996). Neuron 17, 483±490.
neurons. Here, LTD of the postsynaptic response to Linden, D.J., and Connor, J.A. (1995). Annu. Rev. Neurosci. 18,
319±357.iontophoretic application of glutamate is produced by
pairing Purkinje neuron depolarization (mimicking climb- Martin, K.C., and Kandel, E.R. (1996). Neuron 17, 567±570.
ing fiber stimulation) with activation of postsynaptic glu- Silva, A.J., Kogan, J.H., Frankland, P.W., and Kida, S. (1998). Annu.
Rev. Neurosci. 21, 127±148.tamate receptors (mimicking parallel fiber input). In this
reduced system, LTD has both an early, protein synthe- Yin, J.C., and Tully, T. (1996). Curr. Opin. Neurobiol. 6, 264±268.
sis±independent component and a late, protein synthe-
sis±dependent component (Linden, 1996). Now, the Lin-
den group has gone on to show that late LTD in Purkinje
neurons requires CREB activation and that this activa-
tion requires CaMKIV. Upsetting the Balance:Using particle-mediated gene transfection to provide
VGF and the Regulationa powerful molecular scalpel, Ahn et al. (1999) find that
expression of a dominant-negative form of CREB (which of Body Weight
inhibits CREB binding to DNA and gene activation)
blocks late, but not early, LTD. Dominant-negative forms
of CaMKII and CaMKIV, as well as a calmodulin trap
Animal survival depends upon the ability to maintain athat is targeted to the nucleus, also inhibit late, but not
relatively constant body mass despite varying accessearly, LTD. The authors performed a series of careful
to food. The last five years have seen a revolution in ourcontrol measurements to show that the inhibitory effects
understanding of this difficult balancing act, providingof these constructs were not due to inhibition of the
molecular and genetic confirmation of the classical ªset-early calcium signaling pathways necessary for the in-
pointº model of energy homeostasis. In order to regulateduction of LTD. A role for CaMKIV is consistent with
body mass, an animal must first be able to monitorstudies in hippocampal neurons that show that Ca21-
energy stored as fat and then adjust food intake anddependent activation of CREB depends on the translo-
energy expenditure appropriately. While there has beencation of Ca21/CaM to the nucleus, where it activates
an explosion of knowledge about how fat stores areCaMKIV, the principle nuclear isoform of CaM kinase
measured and appetite regulated, relatively less has(Deisseroth et al., 1998). Inhibition of other protein kinase
been learned about how the brain regulates energy ex-cascades implicated in hippocampal LTP, such as PKA
penditure. In this issue of Neuron, Hahm et al. (1999)and p42/p44 MAP kinases, failed to block LTD in the
Purkinje neurons. report the surprising result that mice lacking VGF, a
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secreted neuropeptide of previously unknown function, One answer as to why these mice are so underweight
comes from the analysis of energy expenditure. Vgf2/2display dramatically decreased body weight and body
fat. Interestingly, the major defect in these mice appears mice consume twice as much oxygen at rest (normalized
to body weight) as do wild-type littermates. In addition,to be excess and inappropriate energy expenditure de-
spite dramatic weight loss. they display increased locomotor activity, covering
nearly 10 times as much distance as control mice. ThisAnimals defend a ªset pointº for body weight, with
the hypothalamus playing a central role: lesions of the is in stark contrast to the expected behavior of a starved
animal, which would typically reduce metabolic expen-medial hypothalamus lead to hyperphagia and obesity,
while destruction of the lateral hypothalamus causes ditures. Interestingly, the raised oxygen consumption in
Vgf2/2 mice occurs despite apparently normal sympa-hypophagia and weight loss. A series of genetic and
molecular studies have shown that the amount of energy thetic tone (measured via heart rate and adrenal cate-
cholamine content) and somewhat reduced levels ofstored as fat is reflected in the level of a circulating
hormone, leptin, which acts via cell surface receptors thyroid hormone. Thus, despite appropriate regulation
of the two known efferent pathways that regulate energyin the hypothalamus. In the absence of leptin signaling
(caused either by starvation or mutation), an adaptive expenditure, the animals burn calories at an accelerated
rate.response ensues: animals eat more and burn fewer calo-
ries. The effects on appetite are mediated by a grow- Thus, VGF appears to play a novel and essential role
in how energy expenditure is modulated in response toing list of hypothalamic mediators, including melano-
cortin receptor MC4 (and its modulators POMC/a-MSH, starvation. Consistent with this model, Hahm et al. (1999)
demonstrate that hypothalamic Vgf expression is in-AGRP, MCH, and mahogany), neuropeptide Y, CRH,
CART, and the orexins/hypocretin. Regulation of energy duced in starved, wild-type mice. However, many ques-
tions remain. First, it is not proven that VGF acts primarilyexpenditure is less well understood, but is thought to in-
volve changes in sympathetic tone (mediated by b-adren- at the hypothalamus. Vgf is broadly expressed (Snyder
and Salton, 1998), including in the adrenal medulla (siteergic signaling) and thyroid hormone. Several excellent
reviews have recently covered these topics in detail of catecholamine synthesis) and pituitary. It is interest-
ing in this regard that the authors' unpublished data(Flier and Maratos-Flier, 1998; Friedman and Halaas,
1998; Hirsch et al., 1998). demonstrate that Vgf2/2 mice remain lean despite hypo-
thalamic lesions that normally cause obesity. Tissue-Now, Hahm et al. (1999) report the unexpected result
that mice lacking a functional copy of the Vgf gene specific ablation of VGF signaling will help resolve the
relevant site of action.display a 50% reduction in total body weight with a
disproportionate reduction in fat stores. To understand It will also be critical to disentangle the relative contri-
bution to energy expenditure of skeletal muscle activitythe mechanistic basis of the phenotype, the authors
investigated known regulators of body weight in the (possibly driven by higher cortical centers), basal meta-
bolic rate, and adaptive (nonshivering) thermogenesis.Vgf2/2 mice. Consistent with depleted fat stores, leptin
levels in the mutant mice are ,10% those in wild-type For example, to examine the role of adaptive thermogen-
esis, it will be of interest to create mice that lack bothcontrols. The characteristic hypothalamic response to
starvation appears intact: levels of the appetite-stimu- Vgf and brown fat (Lowell et al., 1993). If the major source
of energy expenditure is thermogenesis in brown fat,lating peptides NPY and AGRP were increased and
those of POMC (precursor to the appetite-repressing then removing this tissue should mitigate the effects of
the Vgf mutation. In addition, blocking the action ofMC4 agonist a-MSH) decreased, similar to changes pre-
viously observed in starved, wild-type mice. In addition, b-adrenergic receptors and thyroid hormone in Vgf2/2
mice would determine whether increased energy expen-two other hypothalamically mediated responses to star-
vationÐinfertility and reduced thyroid hormone levelsÐ diture is independent of these hormonal systems. It will
be important to investigate whether loss of VGF functionare also seen. Thus, the hypothalamus in the Vgf2/2 mice
appears to sense that the animals are underweight, and can compensate for obesity caused by mutations in
leptin (Zhang et al., 1994), MC4 (Huszar et al., 1997),responds appropriately. Why, then, are Vgf2/2 mice so
thin? and other hypothalamic mediators. Finally, another im-
portant direction will be to determine whether sequenceOne possibility is that the low body weight in Vgf2/2
mice is attributable to a primary defect in eating behav- variants in Vgf are associated with human weight dis-
orders.ior. Apparently this is not the case, as the mutant mice
eat the same amount as do wild-type controls. When Along these lines, it is worth considering how closely
the Vgf2/2 phenotype relates to human disease states.normalized to their decreased body weight, this repre-
sents a 50% increase in calories per gram. However, Obviously, increased energy expenditure can result in
excessive weight loss despite normal or increased foodsince Vgf2/2 mice do not eat enough to maintain normal
body weight, it is important to know whether the animal's intake: examples include competitive athletes and some
forms of anorexia nervosa. Furthermore, nonexerciseappetite is maximally increased and appropriate to the
degree of starvation. In fact, the Vgf2/2 mice are capable activity thermogenesis (ªfidgetingº) may be a significant
determinant of human weight status (Levine et al., 1999).of eating more: when briefly starved, Vgf2/2 mice acutely
increase their food intake. However, it is difficult to com- Finally, use of stimulants (such as amphetamines) can
increase energy expenditure and dampen appetite. Ofpare acute refeeding to chronic intake, since animals
may temporarily consume calories at a higher rate than course, amphetamine use has fallen into disfavor be-
cause of side effects and dependency. Thus, the appro-is sustainable at steady state. Thus, while this issue
requires further investigation, it appears that the primary priateness of VGF as a drug target for human obesity
will depend upon how these initial mouse experimentsdefect in Vgf2/2 mice is not undereating.
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translate to human biology, and how cleanly VGF block-
ade might affect weight without unwanted side effects.
Of concern in this regard is the increased mortality ob-
served in Vgf2/2 mice. Regardless, the results of Hahm
et al. (1999) indicate that VGF will be under close scrutiny
for years to come.
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